You can:
Name | Nociceptin receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | OPRL1 |
Synonym | Orphanin FQ receptor OP4 NOPr NOP-r NOP receptor [ Show all ] |
Disease | Inflammatory disease Major depressive disorder Central nervous system disease Heart failure Anxiety disorder [ Show all ] |
Length | 370 |
Amino acid sequence | MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA |
UniProt | P41146 |
Protein Data Bank | 5dhh, 5dhg, 4ea3 |
GPCR-HGmod model | P41146 |
3D structure model | This structure is from PDB ID 5dhh. |
BioLiP | BL0328039,BL0328040, BL0328041,BL0328042, BL0227293,BL0227294 |
Therapeutic Target Database | T52921 |
ChEMBL | CHEMBL2014 |
IUPHAR | 320 |
DrugBank | BE0002378 |
Name | nociceptin(1-13)NH2 |
---|---|
Molecular formula | C61H100N22O15 |
IUPAC name | (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-phenylpropanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanamide |
Molecular weight | 1381.61 |
Hydrogen bond acceptor | 20 |
Hydrogen bond donor | 22 |
XlogP | -7.0 |
Synonyms | H-FGGFTGARKSARK-NH2 nociceptin(1-13)-NH2 BDBM85822 NC(1-13)NH2 OFQ/N [ Show all ] |
Inchi Key | RHMALYOXPBRJBG-CGUXNFSNSA-N |
Inchi ID | InChI=1S/C61H100N22O15/c1-34(75-47(87)32-74-59(98)49(36(3)85)83-57(96)44(29-38-18-8-5-9-19-38)77-48(88)31-72-46(86)30-73-53(92)39(64)28-37-16-6-4-7-17-37)51(90)79-43(23-15-27-71-61(68)69)55(94)81-41(21-11-13-25-63)56(95)82-45(33-84)58(97)76-35(2)52(91)80-42(22-14-26-70-60(66)67)54(93)78-40(50(65)89)20-10-12-24-62/h4-9,16-19,34-36,39-45,49,84-85H,10-15,20-33,62-64H2,1-3H3,(H2,65,89)(H,72,86)(H,73,92)(H,74,98)(H,75,87)(H,76,97)(H,77,88)(H,78,93)(H,79,90)(H,80,91)(H,81,94)(H,82,95)(H,83,96)(H4,66,67,70)(H4,68,69,71)/t34-,35-,36+,39-,40-,41-,42-,43-,44-,45-,49-/m0/s1 |
PubChem CID | 6324645 |
ChEMBL | CHEMBL384755 |
IUPHAR | 1682 |
BindingDB | 50106479, 85822 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Activity | 100.0 % | PMID18624395 | ChEMBL |
EC50 | 0.3236 nM | PMID11689082 | ChEMBL |
EC50 | 0.78 nM | PMID18624395 | BindingDB,ChEMBL |
EC50 | 1.12 nM | PMID11689089 | BindingDB,ChEMBL |
EC50 | 7.82 nM | PMID18624395 | BindingDB,ChEMBL |
Emax | -102.0 % | PMID11689082 | ChEMBL |
Emax | 106.0 % | PMID11689089 | ChEMBL |
IC50 | 0.353 nM | PMID11689089 | BindingDB,ChEMBL |
Ki | 0.0398108 - 0.0794328 nM | PMID12967935, PMID10369464, PMID12070757, PMID9191955 | IUPHAR |
Ki | 0.14 nM | PMID15509719 | BindingDB |
Ki | 0.2 nM | PMID15855355 | BindingDB |
Ki | 0.35 nM | PMID18624395 | BindingDB,ChEMBL |
Ki | 0.62 nM | PMID18624395 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417